-
-
-
-
-
-
-
Kyverna Therapeutics Inc (KYTX) PT Raised to $27 at Wells Fargo
-
-
-
-
-
-
-
Kyverna Therapeutics, Inc. (KYTX) Reports Q1 Loss of $1.03
-
-
-
-
-
-
-
KYTX FINAL DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important February 7 Deadline in Securities Class Action - KY
-
-
-
-
-
-
-
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
-
-
-
-
-
-
-
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
-
-
-
-
-
-
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
-
-
-
-
-
-
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

